PROCEPT BioRobotics Corporation
PRCTNASDAQHealthcare● Active
$28.60
+$0.77(+2.77%)
Market Cap$1.6B
P/E Ratio—
52W High$66.85
52W Low$19.35
PROCEPT BioRobotics Corporation（PRCT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PRCT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.31B | $0.22B | $0.14B | $0.08B | $0.03B |
| Cost of Revenue | $0.11B | $0.09B | $0.07B | $0.04B | $0.02B |
| Gross Profit | $0.20B | $0.14B | $0.07B | $0.04B | $0.02B |
| Gross Margin %(computed) | 63.70% | 61.07% | 52.17% | 49.44% | 46.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.06B | $0.05B | $0.03B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.30B | $0.23B | $0.18B | $0.12B | $0.07B |
| Operating Income | ($0.10B) | ($0.10B) | ($0.11B) | ($0.08B) | ($0.05B) |
| Operating Margin %(computed) | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Income Before Tax | ($0.10B) | ($0.09B) | ($0.11B) | ($0.09B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.10B) | ($0.09B) | ($0.11B) | ($0.09B) | ($0.06B) |
| Net Margin %(computed) | -31.02% | -40.72% | -77.76% | -116.18% | -173.62% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.72 | $-1.75 | $-2.24 | $-1.96 | $-1.37 |
| Wtd Avg Shares | 0.06B | 0.05B | 0.05B | 0.04B | 0.04B |
| EBITDA | ($0.10B) | ($0.08B) | ($0.10B) | ($0.08B) | ($0.05B) |
| EBITDA Margin %(computed) | -31.64% | -36.52% | -72.03% | -105.49% | -147.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解PROCEPT BioRobotics Corporation
关于PROCEPT BioRobotics Corporation（PRCT）损益表
PROCEPT BioRobotics Corporation（PRCT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，PRCT实现营收$0.31B，毛利润$0.20B（毛利率63.70%），净利润($0.10B)（净利率-31.02%）。
常见问题
PRCT · 4 问PROCEPT BioRobotics Corporation（PRCT）2025财年营收为$0.31B，同比up37.2%。
PRCT revenuePRCT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08